• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠NPC1缺乏与胎儿生长受限、新生儿致死率及肺部病理异常有关。

NPC1 Deficiency in Mice is Associated with Fetal Growth Restriction, Neonatal Lethality and Abnormal Lung Pathology.

作者信息

Rodriguez-Gil Jorge L, Watkins-Chow Dawn E, Baxter Laura L, Yokoyama Tadafumi, Zerfas Patricia M, Starost Matthew F, Gahl William A, Malicdan May Christine V, Porter Forbes D, Platt Frances M, Pavan William J

机构信息

Genomics, Development and Disease Section, Genetic Disease Research Branch, NHGRI, NIH, Bethesda, MD, 20892, USA.

Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK.

出版信息

J Clin Med. 2019 Dec 19;9(1):12. doi: 10.3390/jcm9010012.

DOI:10.3390/jcm9010012
PMID:31861571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7019814/
Abstract

The rare lysosomal storage disorder Niemann-Pick disease type C1 (NPC1) arises from mutation of , which encodes a lysosomal transmembrane protein essential for normal transport and trafficking of cholesterol and sphingolipids. NPC1 is highly heterogeneous in both clinical phenotypes and age of onset. Previous studies have reported sub-Mendelian survival rates for mice homozygous for various mutant alleles but have not studied the potential mechanisms underlying this phenotype. We performed the first developmental analysis of a mouse model, , and discovered significant fetal growth restriction in homozygous mutants beginning at E16.5. mice also exhibited cyanosis, increased respiratory effort, and over 50% lethality at birth. Analysis of neonatal lung tissues revealed lipid accumulation, notable abnormalities in surfactant, and enlarged alveolar macrophages, suggesting that lung abnormalities may be associated with neonatal lethality in mice. The phenotypic severity of the model facilitated this first analysis of perinatal lethality and lung pathology in an NPC1 model organism, and this model may serve as a useful resource for developing treatments for respiratory complications seen in NPC1 patients.

摘要

罕见的溶酶体贮积症C1型尼曼-皮克病(NPC1)由 基因突变引起,该基因编码一种溶酶体跨膜蛋白,对胆固醇和鞘脂的正常转运至关重要。NPC1在临床表型和发病年龄上具有高度异质性。先前的研究报道了各种突变等位基因纯合小鼠的亚孟德尔生存率,但尚未研究这种表型背后的潜在机制。我们对一种小鼠模型 进行了首次发育分析,发现纯合突变体从E16.5开始出现显著的胎儿生长受限。 小鼠还表现出发绀、呼吸费力增加,出生时死亡率超过50%。对新生小鼠肺组织的分析显示有脂质蓄积、表面活性剂明显异常以及肺泡巨噬细胞增大,提示肺部异常可能与 小鼠的新生儿致死率有关。 模型的表型严重程度有助于对NPC1模式生物中的围产期致死率和肺部病理学进行首次分析,该模型可能为开发治疗NPC1患者所见呼吸并发症的方法提供有用资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a993/7019814/8de9538f27ad/jcm-09-00012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a993/7019814/f961d0593a2d/jcm-09-00012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a993/7019814/8de9538f27ad/jcm-09-00012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a993/7019814/f961d0593a2d/jcm-09-00012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a993/7019814/8de9538f27ad/jcm-09-00012-g002.jpg

相似文献

1
NPC1 Deficiency in Mice is Associated with Fetal Growth Restriction, Neonatal Lethality and Abnormal Lung Pathology.小鼠NPC1缺乏与胎儿生长受限、新生儿致死率及肺部病理异常有关。
J Clin Med. 2019 Dec 19;9(1):12. doi: 10.3390/jcm9010012.
2
Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1.遗传背景改变尼曼-匹克病 C1 型小鼠模型的表型严重程度和寿命。
Dis Model Mech. 2020 Mar 13;13(3):dmm042614. doi: 10.1242/dmm.042614.
3
Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.由于尼曼-匹克病 C1 型(NPC1)或 C2 型(NPC2)导致的动物模型中的肺部异常。
PLoS One. 2013 Jul 2;8(7):e67084. doi: 10.1371/journal.pone.0067084. Print 2013.
4
Different Trafficking Phenotypes of Niemann-Pick C1 Gene Mutations Correlate with Various Alterations in Lipid Storage, Membrane Composition and Miglustat Amenability.尼曼-匹克 C1 基因突变的不同转运表型与脂质储存、膜组成和米格列醇适应性的各种改变相关。
Int J Mol Sci. 2020 Mar 19;21(6):2101. doi: 10.3390/ijms21062101.
5
Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for screening of candidate therapeutic compounds.在斑马鱼中建立尼曼-匹克病 C1 型模型:筛选候选治疗化合物的强大平台。
Dis Model Mech. 2018 Aug 15;11(9):dmm034165. doi: 10.1242/dmm.034165.
6
Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.尼曼-匹克 C1 型小鼠运动技能习得发育迟缓揭示小脑形态发生异常。
Acta Neuropathol Commun. 2016 Sep 1;4(1):94. doi: 10.1186/s40478-016-0370-z.
7
Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.尼曼-匹克C型病小鼠肺胆固醇代谢、脂质含量和组织学的个体发育变化。
Biochim Biophys Acta. 2014 Jan;1841(1):54-61. doi: 10.1016/j.bbalip.2013.09.010. Epub 2013 Sep 26.
8
A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.一种新型载有 D1005G-Npc1 突变的尼曼-匹克 C 型病的小鼠模型,与常见的人类突变相当。
Hum Mol Genet. 2012 Feb 15;21(4):730-50. doi: 10.1093/hmg/ddr505. Epub 2011 Nov 2.
9
FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.FTY720/芬戈莫德可增加尼曼-匹克C型突变成纤维细胞中NPC1和NPC2的表达,并减少胆固醇和鞘脂的积累。
FASEB J. 2017 Apr;31(4):1719-1730. doi: 10.1096/fj.201601041R. Epub 2017 Jan 12.
10
Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1.通过改变鞘脂转运来检测尼曼-匹克C变异体及其与NPC1特定结构域内突变的相关性
Am J Hum Genet. 2001 Jun;68(6):1361-72. doi: 10.1086/320599. Epub 2001 May 9.

引用本文的文献

1
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunction.GM2神经节苷脂沉积症中的质膜重塑导致突触功能障碍。
PLoS Biol. 2025 Jul 3;23(7):e3003265. doi: 10.1371/journal.pbio.3003265. eCollection 2025 Jul.
2
Cholesterol and COVID-19-therapeutic opportunities at the host/virus interface during cell entry.胆固醇与 COVID-19——细胞进入过程中宿主/病毒界面的治疗机会。
Life Sci Alliance. 2024 Feb 22;7(5). doi: 10.26508/lsa.202302453. Print 2024 May.
3
Organ Weights in Mutant Mice Partly Normalized by Various Pharmacological Treatment Approaches.

本文引用的文献

1
Animal models for Niemann-Pick type C: implications for drug discovery & development.尼曼-匹克 C 型动物模型:对药物发现与开发的影响。
Expert Opin Drug Discov. 2019 May;14(5):499-509. doi: 10.1080/17460441.2019.1588882. Epub 2019 Mar 19.
2
Structural Basis for Cholesterol Transport-like Activity of the Hedgehog Receptor Patched.Hedgehog 受体 patched 胆固醇转运样活性的结构基础。
Cell. 2018 Nov 15;175(5):1352-1364.e14. doi: 10.1016/j.cell.2018.10.026. Epub 2018 Nov 8.
3
Lysosomal storage diseases.溶酶体贮积症。
各种药物处理方法使突变小鼠的器官重量部分恢复正常。
Int J Mol Sci. 2022 Dec 29;24(1):573. doi: 10.3390/ijms24010573.
4
The Cerebellum in Niemann-Pick C1 Disease: Mouse Versus Man.尼曼-匹克C1病中的小脑:小鼠与人类的对比
Cerebellum. 2023 Feb;22(1):102-119. doi: 10.1007/s12311-021-01347-3. Epub 2022 Jan 18.
5
Anti-Inflammatory Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Pathology in Niemann-Pick Type C Disease.抗炎间充质基质细胞衍生的细胞外囊泡改善尼曼-匹克C型病的病理状况。
Biomedicines. 2021 Dec 8;9(12):1864. doi: 10.3390/biomedicines9121864.
6
Targeted Disruption of Mouse Dip2B Leads to Abnormal Lung Development and Prenatal Lethality.靶向敲除小鼠 Dip2B 导致肺发育异常和产前致死。
Int J Mol Sci. 2020 Nov 3;21(21):8223. doi: 10.3390/ijms21218223.
7
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.溶酶体:SARS-CoV-2 感染性与尼曼-匹克病 C 型之间的潜在连接点,具有治疗意义。
FASEB J. 2020 Jun;34(6):7253-7264. doi: 10.1096/fj.202000654R. Epub 2020 May 5.
Nat Rev Dis Primers. 2018 Oct 1;4(1):27. doi: 10.1038/s41572-018-0025-4.
4
Pulmonary involvement in Niemann-Pick C type 1.尼曼-匹克 C 型 1 型的肺部受累。
Eur J Pediatr. 2018 Nov;177(11):1609-1615. doi: 10.1007/s00431-018-3219-6. Epub 2018 Jul 31.
5
Structures of human Patched and its complex with native palmitoylated sonic hedgehog.人源 patched 及其与天然棕榈酰化 sonic hedgehog 复合物的结构。
Nature. 2018 Aug;560(7716):128-132. doi: 10.1038/s41586-018-0308-7. Epub 2018 Jul 11.
6
The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammation.溶酶体贮积症的发病机制:从溶酶体过度扩张到异常发育和神经炎症。
Hum Mol Genet. 2018 Aug 1;27(R2):R119-R129. doi: 10.1093/hmg/ddy155.
7
Consensus clinical management guidelines for Niemann-Pick disease type C.尼曼-匹克病 C 型共识临床管理指南。
Orphanet J Rare Dis. 2018 Apr 6;13(1):50. doi: 10.1186/s13023-018-0785-7.
8
Approaches to sample size calculation for clinical trials in rare diseases.罕见病临床试验样本量计算方法。
Pharm Stat. 2018 May;17(3):214-230. doi: 10.1002/pst.1848. Epub 2018 Jan 10.
9
Antisense oligonucleotides: the next frontier for treatment of neurological disorders.反义寡核苷酸:治疗神经紊乱的下一个前沿。
Nat Rev Neurol. 2018 Jan;14(1):9-21. doi: 10.1038/nrneurol.2017.148. Epub 2017 Dec 1.
10
Niemann-Pick disease type C in the newborn period: a single-center experience.尼曼-匹克病 C 型在新生儿期:单中心经验。
Eur J Pediatr. 2017 Dec;176(12):1669-1676. doi: 10.1007/s00431-017-3020-y. Epub 2017 Sep 27.